Employment Support After Hematopoietic Stem Cell Transplantation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorMGH Institute of Health Professions
About this trial
This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by:
1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.
Eligibility criteria
Qualifiers
Received an allogeneic HSCT within the past six months to treat a hematological malignancy.
Screen positive for work-related concerns (i.e., responds "yes" to the question, "Are you concerned about your ability to return to work in the coming six months?")
Disqualifiers
Patients with acute psychiatric or cognitive conditions which the treating clinician believes prohibits informed consent or compliance with the study procedures
We will not enroll the following special populations: adults unable to consent, individuals not yet adults, pregnant women, and prisoners.
Trial design
Treatments tested in this trial
- Work Support (WorkS)
Treatment groups
35 Participants
are divided into 1 treatment groupSponsors and collaborators
MGH Institute of Health Professions
Lead sponsor
Massachusetts General Hospital
Collaborator
Source ClinicalTrials.gov